Medical Technology

@techcrunch.com 1 year ago

Nanopath is looking to drastically change medical diagnostics

@techcrunch.com 2 years ago

Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets

@xconomy.com 4 years ago

Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 4 years ago

Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company

@techcrunch.com 4 years ago

After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt

@techcrunch.com 4 years ago

Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders

@techcrunch.com 5 years ago

Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests

@xconomy.com 5 years ago

Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

@xconomy.com 5 years ago

Renovia Raises $42M to Back Digital Treatment for Incontinence

@xconomy.com 5 years ago

Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO

@xconomy.com 6 years ago

Pfizer, Merck Lead Strata Oncology’s $26M Series B Round

@techcrunch.com 6 years ago

With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas